Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies – WLTW, TTPH, ASRT, MEET

Tuesday, 17. March 2020 15:15

NEW YORK, March 17, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, investigates whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders:

Willis Towers Watson Public Limited Company (NASDAQ: WLTW)
The investigation concerns whether Willis Towers and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the sale of Willis Towers to Aon plc for 1.08 Aon ordinary shares for each Willis Towers ordinary share. If you are a Willis Towers shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/willis-towers-watson-public-limited-company-wltw-stock-merger-aon-plc/.

Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH)
The investigation concerns whether Tetraphase and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Tetraphase to AcelRx Pharmaceuticals, Inc. for 0.6303 shares of AcelRx for each share of Tetraphase. If you are a Tetraphase shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/tetraphase-pharmaceuticals-inc-ttph-stock-merger-acelrx/.

Assertio Therapeutics, Inc. (NASDAQ: ASRT)
The investigation concerns whether Assertio and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed merger between Assertio and Zyla Life Sciences. If you are an Assertio shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/assertio-therapeutics-inc-asrt-stock-merger-zyla-life-sciences/.

The Meet Group, Inc. (NASDAQ: MEET)
The investigation concerns whether Meet Group and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the sale of Meet Group to ProSiebenSat.1’s and General Atlantic’s joint company, NuCom Group, for $6.30 per share. If you are a Meet Group shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/the-meet-group-inc-meet-stock-merger-nucom-group/.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Primary Logo

Related Links: 
Author:
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.